SCHEMBL217854

SCHEMBL217854

Clc1ncc(Br)c(Cl)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25247012 0.79 — —
SCHEMBL246368 0.75 — —
SCHEMBL31586523 0.75 — —
SCHEMBL31259503 0.75 — —
SCHEMBL10034998 0.75 — —
SCHEMBL13202779 0.75 — —
SCHEMBL10161873 0.75 — —
SCHEMBL4145389 0.75 — —
SCHEMBL14594131 0.75 — —
SCHEMBL2183234 0.75 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2841 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119751461-A PKMYT1 inhibitor and preparation method and application thereof 中国药科大学 2025-04-04 — — CN claimed
CN-119504740-A New preparation method of palbociclin 江苏权正检验检测有限公司 2025-02-25 — — CN claimed
CN-119059982-A Hydroxamic acid Mer/HDAC double-target inhibitor and preparation method and application thereof 河北科技大学 2024-12-03 — — CN claimed
CN-118724825-A Mer/HDAC double-target inhibitor and application thereof in preparation of antitumor drugs 河北科技大学 2024-10-01 — — CN claimed
CN-118027006-A 2, 4-Diaminopyrimidine derivative and preparation method and application thereof 温州医科大学附属第一医院 2024-05-14 — — CN claimed
CN-117903147-A Preparation method of treasipril and intermediate thereof 沈阳药科大学 2024-04-19 — — CN claimed
CN-117069663-B Synthesis method of rebaudinib intermediate V and synthesis method of rebaudinib 四川维亚本苑生物科技有限公司 2023-12-26 — — CN claimed
CN-117069663-A Synthesis method of rebaudinib intermediate V and synthesis method of rebaudinib 四川维亚本苑生物科技有限公司 2023-11-17 — — CN claimed
US-20230295144-A1 2-polysubstituted aromatic ring-pyrimidine derivatives, preparation and medical application thereof UNIV ZHEJIANG (CN) 2023-09-21 — — US claimed
CN-112920182-B Preparation method of palbociclib 上海天慈国际药业有限公司 2023-08-01 — — CN claimed
US-10822327-B2 2-substituted aromatic ring-pyrimidine derivative and preparation and application thereof ZHEJIANG UNIVERSITY (CN) 2020-11-03 — — US claimed
CN-111233834-A FAK-targeting compound and markers thereof, and preparation methods and applications of FAK-targeting compound and markers 北京师范大学 2020-06-05 — — CN claimed
EP-3530657-A1 2-POLYSUBSTITUTED AROMATIC RING-PYRIMIDINE DERIVATIVE AND PREPARATION AND MEDICAL USE Zhejiang University (CN) 2019-08-28 — — EP claimed
EP-3530656-A1 2-SUBSTITUTED AROMATIC RING-PYRIMIDINE DERIVATIVE, AND PREPARATION AND APPLICATION THEREOF Zhejiang University (CN) 2019-08-28 — — EP claimed
CN-109721547-A A kind of preparation method of intermediate that treating breast cancer medicines Pa Boxini 陈欣 2019-05-07 — — CN claimed
CN-109206375-A A kind of 5 cyclosubstituted 2,4- diaminopyrimidines with benzene glycinol class formation, its preparation and purposes 中国科学院上海药物研究所 2019-01-15 — — CN claimed
US-7825128-B2 Sulfoximine-substituted pyrimidines, processes for production thereof and use thereof as drugs BAYER SCHERING PHARMA AG (DE) 2010-11-02 — — US claimed
EP-1963282-A1 SULFOXIMINE-SUBSTITUTED PYRIMIDINES , THEIR PREPARATION AND USE AS DRUGS Bayer Schering Pharma Aktiengesellschaft (DE) 2008-09-03 — — EP claimed
US-20070232632-A1 Sulfoximine-substituted pyrimidines, processes for production thereof and use thereof as drugs BAYER INTELLECTUAL PROPERTY GMBH (DE) 2007-10-04 — — US claimed
WO-2007071455-A1 SULFOXIMINE-SUBSTITUTED PYRIMIDINES , THEIR PREPARATION AND USE AS DRUGS BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-06-28 — — WO claimed
Send feedback